Bladder Cancer clinical trials in Australia
26 bladder cancer trials recruiting in Australia
Bladder and urothelial cancers now have multiple immunotherapy and antibody-drug conjugate options. Areas of active research include new combinations for muscle-invasive and non-muscle-invasive bladder cancer.
Describe the diagnosis below and we'll find matching trials.
For information only. Matches are AI generated. Always consult your healthcare team prior to any medical decisions.
Three steps. About 30 seconds.
Describe
Tell us about your bladder cancer in your own words, or use the step-by-step form. Even rough detail works.
Match
We search actively recruiting bladder cancer trials in Australia and explain why each may be relevant to you.
Discuss
Get clear summaries of each trial and questions to ask your doctor. Print or save the results to take to your next appointment.
Bladder Cancer clinical trials: common questions
The things people most often ask about bladder cancer trials.
The bladder wall has several layers, including an inner lining and a layer of muscle. Non-muscle-invasive bladder cancer (NMIBC) is confined to the inner lining and has not grown into the muscle. Muscle-invasive disease has reached the muscle layer and behaves much more aggressively. The distinction is one of the most important in bladder cancer research because the two disease states have very different treatment goals: preserving the bladder is often central in non-muscle-invasive research, while muscle-invasive research looks much more at preventing or treating spread.
The information above is general in nature. Always discuss specific trial options and treatment decisions with your oncologist or treating team.
Search other cancer types
TrialLight covers over 25 cancer types across Australia.